About Fulvira 250mg
Discover Fulvira 250mg, a top-drawer solution in breast cancer therapy now available at an exclusive discount. This new, unparalleled prescription medication contains Fulvestrant in a clear, sterile, single-use pre-filled syringe, delivering exceptional efficacy for hormone receptor positive metastatic breast cancer in adults. Marketed by Emcure and supplied in grandiose 250mg PFS packaging, Fulvira 250mg promises precise, intramuscular delivery and optimal patient safety. Store below 25C. Always use as directed by your physician. Trust Fulvira 250mg, the popular, high-quality choice for cancer care in India and beyond.
Application Areas & Standout Features
Fulvira 250mg is specifically indicated for hormone receptor positive metastatic breast cancer in adult patients. Its application encompasses leading oncology centers, hospitals, and specialized healthcare facilities. This antineoplastic injection is highly valued for its single-use, pre-filled syringe format, ensuring safety and convenience. Fulvira 250mg's physical form as a clear, sterile solution provides easy administration and minimizes risk of infections, making it an optimal option for both patients and medical professionals seeking reliable cancer treatment.
Certifications, Export Markets & Sample Policy
Fulvira 250mg is shipped following stringent regulatory certifications, confirming its safety and quality. Our sample policy accommodates institutions for expenditure evaluation before larger procurement. Main export market(s) include regions beyond India, driven by prompt order completion and professional trading standards. Each order, once finalized, is swiftly shipped to guarantee timely access to this top-tier therapy, supporting effective treatment planning for healthcare providers across the globe.
FAQ's of Fulvira 250mg:
Q: How should Fulvira 250mg be administered?
A: Fulvira 250mg is intended for intramuscular injection and should only be administered by a qualified healthcare professional as per the physician's guidelines.
Q: What is the primary benefit of using Fulvira 250mg?
A: The primary benefit of Fulvira 250mg is its efficacy in treating hormone receptor positive metastatic breast cancer, offering an effective antineoplastic solution for adult patients.
Q: When should Fulvira 250mg be used in breast cancer treatment?
A: Fulvira 250mg is recommended for use in adults diagnosed with hormone receptor positive metastatic breast cancer, as advised by a licensed physician.
Q: Where is Fulvira 250mg manufactured and marketed?
A: Fulvira 250mg is manufactured and marketed in India by Emcure, ensuring quality and authenticity in every pre-filled syringe supplied.
Q: What are the storage guidelines for Fulvira 250mg?
A: Fulvira 250mg should be stored below 25C, and it is essential to refer to the expiry date on the packaging for safe usage.
Q: Is Fulvira 250mg suitable for re-use?
A: No, Fulvira 250mg is supplied in a single-use only pre-filled syringe, designed for one-time administration to ensure safety and sterility.